Tapewire

Nasdaq · USD

QTRX

Quanterix Corp

Export transactions ↓
Tapewire entity
6649
SEC CIK
0001503274
Parsed reports
711

Last 12 months

Inside the activity.

3 purchase rows · 0 sale rows

Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.
Monthly counts
MonthPurchasesSales
Nov 202500
Dec 202500
Jan 202600
Feb 202600
Mar 202600
Apr 202600
May 202610
Jun 202600
Jul 202600
Aug 202620
Sep 202600
Oct 202600

Latest available

Insider transactions

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateOwner / reported roleActivity / securityShares / unitsReported priceReported valueDetails
February 01, 2021 Filed Feb 2, 2021 20:12 UTC
HRUSOVSKY E KEVINDirector · Chairman, President & CEO
SaleCommon Stock 3,700 $65.90 $243,821.86
Disclosure

SEC source: 0001562180-21-000756 · primarydocument.xml · nonDerivative · entry 4

HRUSOVSKY E KEVIN · CIK 0001252546 · Director · Chairman, President & CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 998,139

F5 · kind: The sale of shares was effected pursuant to a Rule 10b5-1 trading plan adopted on December 14, 2020.

F7 · price: This transaction was executed in multiple trades at prices ranging from $65.49 to $66.32. The price reported reflects the weighted average sale price. The reporting person undertakes to provide upon request to the SEC staff, the issuer or any security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

F3 · balance_after: Includes 128,271 restricted stock units and 39,815 shares of common stock that are subject to performance based vesting.

Read SEC document
February 01, 2021 Filed Feb 2, 2021 20:12 UTC
HRUSOVSKY E KEVINDirector · Chairman, President & CEO
SaleCommon Stock 700 $64.70 $45,291.05
Disclosure

SEC source: 0001562180-21-000756 · primarydocument.xml · nonDerivative · entry 3

HRUSOVSKY E KEVIN · CIK 0001252546 · Director · Chairman, President & CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,001,839

F5 · kind: The sale of shares was effected pursuant to a Rule 10b5-1 trading plan adopted on December 14, 2020.

F6 · price: This transaction was executed in multiple trades at prices ranging from $64.22 to $64.96. The price reported reflects the weighted average sale price. The reporting person undertakes to provide upon request to the SEC staff, the issuer or any security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

F3 · balance_after: Includes 128,271 restricted stock units and 39,815 shares of common stock that are subject to performance based vesting.

Read SEC document
February 01, 2021 Filed Feb 2, 2021 20:12 UTC
HRUSOVSKY E KEVINDirector · Chairman, President & CEO
SaleCommon Stock 1,890 $68.49 $129,450.83
Disclosure

SEC source: 0001562180-21-000756 · primarydocument.xml · nonDerivative · entry 2

HRUSOVSKY E KEVIN · CIK 0001252546 · Director · Chairman, President & CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,002,539

F1 · shares: The sales of shares reported on this Form 4 were made solely to cover tax obligations upon the vesting of 7,123 RSUs.

F4 · price: This transaction was executed in multiple trades at prices ranging from $68.27 to $68.63. The price reported reflects the weighted average sale price. The reporting person undertakes to provide upon request to the SEC staff, the issuer or any security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

F3 · balance_after: Includes 128,271 restricted stock units and 39,815 shares of common stock that are subject to performance based vesting.

Read SEC document
February 01, 2021 Filed Feb 2, 2021 20:12 UTC
HRUSOVSKY E KEVINDirector · Chairman, President & CEO
SaleCommon Stock 1,359 $67.93 $92,316.60
Disclosure

SEC source: 0001562180-21-000756 · primarydocument.xml · nonDerivative · entry 1

HRUSOVSKY E KEVIN · CIK 0001252546 · Director · Chairman, President & CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,004,429

F1 · shares: The sales of shares reported on this Form 4 were made solely to cover tax obligations upon the vesting of 7,123 RSUs.

F2 · price: This transaction was executed in multiple trades at prices ranging from $67.25 to $68.23. The price reported reflects the weighted average sale price. The reporting person undertakes to provide upon request to the SEC staff, the issuer or any security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

F3 · balance_after: Includes 128,271 restricted stock units and 39,815 shares of common stock that are subject to performance based vesting.

Read SEC document
February 01, 2021 Filed Feb 3, 2021 02:13 UTC
Mattoon DawnSr. VP, Research Products
SaleCommon Stock 106 $68.49 $7,260.21
Disclosure

SEC source: 0001562180-21-000762 · primarydocument.xml · nonDerivative · entry 2

Mattoon Dawn · CIK 0001731785 · Sr. VP, Research Products

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 30,834

F1 · shares: The sales of shares reported on this Form 4 were made solely to cover tax obligations upon the vesting of 518 RSUs.

F4 · price: This transaction was executed in multiple trades at prices ranging from $68.27 to $68.63. The price reported reflects the weighted average sale price. The reporting person undertakes to provide upon request to the SEC staff, the issuer or any security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

F3 · balance_after: Includes 19,822 restricted stock units.

Read SEC document
February 01, 2021 Filed Feb 3, 2021 02:13 UTC
Mattoon DawnSr. VP, Research Products
SaleCommon Stock 76 $67.93 $5,162.66
Disclosure

SEC source: 0001562180-21-000762 · primarydocument.xml · nonDerivative · entry 1

Mattoon Dawn · CIK 0001731785 · Sr. VP, Research Products

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 30,940

F1 · shares: The sales of shares reported on this Form 4 were made solely to cover tax obligations upon the vesting of 518 RSUs.

F2 · price: This transaction was executed in multiple trades at prices ranging from $67.25 to $68.23. The price reported reflects the weighted average sale price. The reporting person undertakes to provide upon request to the SEC staff, the issuer or any security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

F3 · balance_after: Includes 19,822 restricted stock units.

Read SEC document
February 01, 2021 Filed Feb 3, 2021 01:04 UTC
Chaubal AmolChief Financial Officer
SaleCommon Stock 77 $68.49 $5,273.92
Disclosure

SEC source: 0001562180-21-000755 · primarydocument.xml · nonDerivative · entry 2

Chaubal Amol · CIK 0001773089 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 25,367

F1 · shares: The sales of shares reported on this Form 4 were made solely to cover tax obligations upon the vesting of 380 RSUs.

F4 · price: This transaction was executed in multiple trades at prices ranging from $68.27 to $68.63. The price reported reflects the weighted average sale price. The reporting person undertakes to provide upon request to the SEC staff, the issuer or any security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

F3 · balance_after: Includes 19,181 restricted stock units.

Read SEC document
February 01, 2021 Filed Feb 3, 2021 01:04 UTC
Chaubal AmolChief Financial Officer
SaleCommon Stock 56 $67.93 $3,804.07
Disclosure

SEC source: 0001562180-21-000755 · primarydocument.xml · nonDerivative · entry 1

Chaubal Amol · CIK 0001773089 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 25,444

F1 · shares: The sales of shares reported on this Form 4 were made solely to cover tax obligations upon the vesting of 380 RSUs.

F2 · price: This transaction was executed in multiple trades at prices ranging from $67.25 to $68.23. The price reported reflects the weighted average sale price. The reporting person undertakes to provide upon request to the SEC staff, the issuer or any security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

F3 · balance_after: Includes 19,181 restricted stock units.

Read SEC document
February 01, 2021 Filed Feb 3, 2021 00:56 UTC
Roskey Mark T.SVP, Commercial & Accelerator
SaleCommon Stock 61 $68.49 $4,178.04
Disclosure

SEC source: 0001562180-21-000753 · primarydocument.xml · nonDerivative · entry 2

Roskey Mark T. · CIK 0001724565 · SVP, Commercial & Accelerator

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 21,732

F1 · shares: The sales of shares reported on this Form 4 were made solely to cover tax obligations upon the vesting of 298 RSUs.

F4 · price: This transaction was executed in multiple trades at prices ranging from $68.27 to $68.63. The price reported reflects the weighted average sale price. The reporting person undertakes to provide upon request to the SEC staff, the issuer or any security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

F3 · balance_after: Includes 14,369 restricted stock units.

Read SEC document
February 01, 2021 Filed Feb 3, 2021 00:56 UTC
Roskey Mark T.SVP, Commercial & Accelerator
SaleCommon Stock 44 $67.93 $2,988.91
Disclosure

SEC source: 0001562180-21-000753 · primarydocument.xml · nonDerivative · entry 1

Roskey Mark T. · CIK 0001724565 · SVP, Commercial & Accelerator

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 21,793

F1 · shares: The sales of shares reported on this Form 4 were made solely to cover tax obligations upon the vesting of 298 RSUs.

F2 · price: This transaction was executed in multiple trades at prices ranging from $67.25 to $68.23. The price reported reflects the weighted average sale price. The reporting person undertakes to provide upon request to the SEC staff, the issuer or any security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

F3 · balance_after: Includes 14,369 restricted stock units.

Read SEC document
January 25, 2021 Filed Jan 25, 2021 16:01 UTC
HRUSOVSKY E KEVINDirector · Chairman, President & CEO
SaleCommon Stock 1,500 $78.21 $117,314.10
Disclosure

SEC source: 0001562180-21-000502 · primarydocument.xml · nonDerivative · entry 2

HRUSOVSKY E KEVIN · CIK 0001252546 · Director · Chairman, President & CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,005,788

F1 · kind: The sale of shares was effected pursuant to a Rule 10b5-1 trading plan adopted on December 14, 2020.

F4 · price: This transaction was executed in multiple trades at prices ranging from $78.06 to $78.33. The price reported reflects the weighted average sale price. The reporting person undertakes to provide upon request to the SEC staff, the issuer or any security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

F3 · balance_after: Includes 135,394 restricted stock units and 39,815 shares of common stock that are subject to performance based vesting.

Read SEC document
January 25, 2021 Filed Jan 25, 2021 16:01 UTC
HRUSOVSKY E KEVINDirector · Chairman, President & CEO
SaleCommon Stock 3,500 $77.64 $271,741.75
Disclosure

SEC source: 0001562180-21-000502 · primarydocument.xml · nonDerivative · entry 1

HRUSOVSKY E KEVIN · CIK 0001252546 · Director · Chairman, President & CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,007,288

F1 · kind: The sale of shares was effected pursuant to a Rule 10b5-1 trading plan adopted on December 14, 2020.

F2 · price: This transaction was executed in multiple trades at prices ranging from $77.06 to $78.02. The price reported reflects the weighted average sale price. The reporting person undertakes to provide upon request to the SEC staff, the issuer or any security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

F3 · balance_after: Includes 135,394 restricted stock units and 39,815 shares of common stock that are subject to performance based vesting.

Read SEC document
January 22, 2021 Filed Jan 22, 2021 23:47 UTC
Duffy David C.SVP R&D and CTO
SaleCommon Stock 1,667 $79.29 $132,176.43
Disclosure

SEC source: 0001562180-21-000487 · primarydocument.xml · nonDerivative · entry 1

Duffy David C. · CIK 0001724566 · SVP R&D and CTO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 39,473

F1 · shares: The sale of shares reported on this Form 4 was made pursuant to a Rule 10b5-1 trading plan adopted on May 15, 2020.

F2 · balance_after: Includes 11,389 restricted stock units.

Read SEC document
January 19, 2021 Filed Jan 21, 2021 19:55 UTC
HRUSOVSKY E KEVINDirector · Chairman, President & CEO
SaleCommon Stock 1,000 $76.36 $76,361.00
Disclosure

SEC source: 0001562180-21-000446 · primarydocument.xml · nonDerivative · entry 3

HRUSOVSKY E KEVIN · CIK 0001252546 · Director · Chairman, President & CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,010,788

F1 · kind: The sale of shares was effected pursuant to a Rule 10b5-1 trading plan adopted on December 14, 2020.

F5 · price: This transaction was executed in multiple trades at prices ranging from $76.11 to $76.68. The price reported reflects the weighted average sale price. The reporting person undertakes to provide upon request to the SEC staff, the issuer or any security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

F3 · balance_after: Includes 135,394 restricted stock units and 39,815 shares of common stock that are subject to performance based vesting.

Read SEC document
January 19, 2021 Filed Jan 21, 2021 19:55 UTC
HRUSOVSKY E KEVINDirector · Chairman, President & CEO
SaleCommon Stock 950 $75.08 $71,322.49
Disclosure

SEC source: 0001562180-21-000446 · primarydocument.xml · nonDerivative · entry 2

HRUSOVSKY E KEVIN · CIK 0001252546 · Director · Chairman, President & CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,011,788

F1 · kind: The sale of shares was effected pursuant to a Rule 10b5-1 trading plan adopted on December 14, 2020.

F4 · price: This transaction was executed in multiple trades at prices ranging from $74.53 to $75.35. The price reported reflects the weighted average sale price. The reporting person undertakes to provide upon request to the SEC staff, the issuer or any security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

F3 · balance_after: Includes 135,394 restricted stock units and 39,815 shares of common stock that are subject to performance based vesting.

Read SEC document
January 19, 2021 Filed Jan 21, 2021 19:55 UTC
HRUSOVSKY E KEVINDirector · Chairman, President & CEO
SaleCommon Stock 3,050 $73.76 $224,962.82
Disclosure

SEC source: 0001562180-21-000446 · primarydocument.xml · nonDerivative · entry 1

HRUSOVSKY E KEVIN · CIK 0001252546 · Director · Chairman, President & CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,012,738

F1 · kind: The sale of shares was effected pursuant to a Rule 10b5-1 trading plan adopted on December 14, 2020.

F2 · price: This transaction was executed in multiple trades at prices ranging from $73.47 to $74.30. The price reported reflects the weighted average sale price. The reporting person undertakes to provide upon request to the SEC staff, the issuer or any security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

F3 · balance_after: Includes 135,394 restricted stock units and 39,815 shares of common stock that are subject to performance based vesting.

Read SEC document
January 11, 2021 Filed Jan 13, 2021 17:01 UTC Exercise / conversionStock Option (right to buy) · Derivative 29,162 $0.00 Strike: $8.16 $0.00
Disclosure

SEC source: 0001562180-21-000339 · primarydocument.xml · derivative · entry 11

DEKKERS MARIJN E · CIK 0001216068 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,951

Underlying: Common Stock · 29,162 shares

Expires 2027-03-31

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F8 · derivative.exercise_date: The option vests as to 25% of the shares on March 13, 2018 and vests as to an additional 2.083% of the shares per month thereafter until February 28, 2021.

Read SEC document
January 11, 2021 Filed Jan 13, 2021 17:01 UTC Exercise / conversionStock Option (Right to Buy) · Derivative 7,900 $0.00 Strike: $14.80 $0.00
Disclosure

SEC source: 0001562180-21-000339 · primarydocument.xml · derivative · entry 10

DEKKERS MARIJN E · CIK 0001216068 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 7,900 shares

Expires 2028-08-07

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
January 11, 2021 Filed Jan 13, 2021 17:01 UTC Exercise / conversionStock Option (Right to Buy) · Derivative 7,900 $0.00 Strike: $18.24 $0.00
Disclosure

SEC source: 0001562180-21-000339 · primarydocument.xml · derivative · entry 9

DEKKERS MARIJN E · CIK 0001216068 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 7,900 shares

Expires 2029-01-02

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
January 11, 2021 Filed Jan 13, 2021 17:01 UTC SaleCommon Stock 8,199 $51.08 $418,822.14
Disclosure

SEC source: 0001562180-21-000339 · primarydocument.xml · nonDerivative · entry 8

DEKKERS MARIJN E · CIK 0001216068 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 9,080

F1 · kind: The sale of shares was effected pursuant to a Rule 10b5-1 trading plan adopted on December 9, 2020.

F6 · price: This transaction was executed in multiple trades at prices ranging from $50.79 to $51.64. The price reported reflects the weighted average sale price. The reporting person undertakes to provide upon request to the SEC staff, the issuer or any security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

F7 · balance_after: Includes 2,270 restricted stock units.

Read SEC document
January 11, 2021 Filed Jan 13, 2021 17:01 UTC SaleCommon Stock 4,400 $50.38 $221,657.48
Disclosure

SEC source: 0001562180-21-000339 · primarydocument.xml · nonDerivative · entry 7

DEKKERS MARIJN E · CIK 0001216068 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 17,279

F1 · kind: The sale of shares was effected pursuant to a Rule 10b5-1 trading plan adopted on December 9, 2020.

F5 · price: This transaction was executed in multiple trades at prices ranging from $49.79 to $50.78. The price reported reflects the weighted average sale price. The reporting person undertakes to provide upon request to the SEC staff, the issuer or any security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

Read SEC document
January 11, 2021 Filed Jan 13, 2021 17:01 UTC SaleCommon Stock 2,333 $49.16 $114,681.88
Disclosure

SEC source: 0001562180-21-000339 · primarydocument.xml · nonDerivative · entry 6

DEKKERS MARIJN E · CIK 0001216068 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 21,679

F1 · kind: The sale of shares was effected pursuant to a Rule 10b5-1 trading plan adopted on December 9, 2020.

F4 · price: This transaction was executed in multiple trades at prices ranging from $48.74 to $49.70. The price reported reflects the weighted average sale price. The reporting person undertakes to provide upon request to the SEC staff, the issuer or any security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

Read SEC document
January 11, 2021 Filed Jan 13, 2021 17:01 UTC SaleCommon Stock 22,830 $47.87 $1,092,760.23
Disclosure

SEC source: 0001562180-21-000339 · primarydocument.xml · nonDerivative · entry 5

DEKKERS MARIJN E · CIK 0001216068 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 24,012

F1 · kind: The sale of shares was effected pursuant to a Rule 10b5-1 trading plan adopted on December 9, 2020.

F3 · price: This transaction was executed in multiple trades at prices ranging from $47.47 to $48.43. The price reported reflects the weighted average sale price. The reporting person undertakes to provide upon request to the SEC staff, the issuer or any security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

Read SEC document
January 11, 2021 Filed Jan 13, 2021 17:01 UTC SaleCommon Stock 7,200 $47.17 $339,592.32
Disclosure

SEC source: 0001562180-21-000339 · primarydocument.xml · nonDerivative · entry 4

DEKKERS MARIJN E · CIK 0001216068 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 46,842

F1 · kind: The sale of shares was effected pursuant to a Rule 10b5-1 trading plan adopted on December 9, 2020.

F2 · price: This transaction was executed in multiple trades at prices ranging from $46.47 to $47.46. The price reported reflects the weighted average sale price. The reporting person undertakes to provide upon request to the SEC staff, the issuer or any security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

Read SEC document
January 11, 2021 Filed Jan 13, 2021 17:01 UTC Exercise / conversionCommon Stock 29,162 $8.16 $237,961.92
Disclosure

SEC source: 0001562180-21-000339 · primarydocument.xml · nonDerivative · entry 3

DEKKERS MARIJN E · CIK 0001216068 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 54,042

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
January 11, 2021 Filed Jan 13, 2021 17:01 UTC Exercise / conversionCommon Stock 7,900 $14.80 $116,920.00
Disclosure

SEC source: 0001562180-21-000339 · primarydocument.xml · nonDerivative · entry 2

DEKKERS MARIJN E · CIK 0001216068 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 24,880

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
January 11, 2021 Filed Jan 13, 2021 17:01 UTC Exercise / conversionCommon Stock 7,900 $18.24 $144,096.00
Disclosure

SEC source: 0001562180-21-000339 · primarydocument.xml · nonDerivative · entry 1

DEKKERS MARIJN E · CIK 0001216068 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 16,980

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
January 05, 2021 Filed Jan 6, 2021 16:21 UTC
Fry John JGeneral Counsel & Secretary
SaleCommon Stock 153 $44.13 $6,752.15
Disclosure

SEC source: 0001562180-21-000187 · primarydocument.xml · nonDerivative · entry 1

Fry John J · CIK 0001419544 · General Counsel & Secretary

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 31,885

F1 · shares: The sales of shares reported on this Form 4 were made solely to cover tax obligations upon the vesting of 468 RSUs.

F2 · price: This transaction was executed in multiple trades at prices ranging from $43.91 to $44.62. The price reported reflects the weighted average sale price. The reporting person undertakes to provide upon request to the SEC staff, the issuer or any security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

F3 · balance_after: Includes 24,744 restricted stock units.

Read SEC document
January 05, 2021 Filed Jan 6, 2021 16:21 UTC
HRUSOVSKY E KEVINDirector · Chairman, President & CEO
SaleCommon Stock 3,510 $44.13 $154,902.27
Disclosure

SEC source: 0001562180-21-000186 · primarydocument.xml · nonDerivative · entry 1

HRUSOVSKY E KEVIN · CIK 0001252546 · Director · Chairman, President & CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,015,788

F1 · shares: The sales of shares reported on this Form 4 were made solely to cover tax obligations upon the vesting of 7,123 RSUs.

F2 · price: This transaction was executed in multiple trades at prices ranging from $43.91 to $44.62. The price reported reflects the weighted average sale price. The reporting person undertakes to provide upon request to the SEC staff, the issuer or any security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

F3 · balance_after: Includes 135,394 restricted stock units and 39,815 shares of common stock that are subject to performance based vesting.

Read SEC document
January 05, 2021 Filed Jan 6, 2021 21:21 UTC
Mattoon DawnSr. VP, Research Products
SaleCommon Stock 170 $44.13 $7,502.39
Disclosure

SEC source: 0001562180-21-000185 · primarydocument.xml · nonDerivative · entry 1

Mattoon Dawn · CIK 0001731785 · Sr. VP, Research Products

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 31,016

F1 · shares: The sales of shares reported on this Form 4 were made solely to cover tax obligations upon the vesting of 518 RSUs.

F2 · price: This transaction was executed in multiple trades at prices ranging from $43.91 to $44.62. The price reported reflects the weighted average sale price. The reporting person undertakes to provide upon request to the SEC staff, the issuer or any security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

F3 · balance_after: Includes 20,340 restricted stock units.

Read SEC document
January 05, 2021 Filed Jan 6, 2021 21:23 UTC
Chaubal AmolChief Financial Officer
SaleCommon Stock 124 $44.13 $5,472.33
Disclosure

SEC source: 0001562180-21-000190 · primarydocument.xml · nonDerivative · entry 1

Chaubal Amol · CIK 0001773089 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 25,500

F1 · shares: The sales of shares reported on this Form 4 were made solely to cover tax obligations upon the vesting of 380 RSUs.

F2 · price: This transaction was executed in multiple trades at prices ranging from $43.91 to $44.62. The price reported reflects the weighted average sale price. The reporting person undertakes to provide upon request to the SEC staff, the issuer or any security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

F3 · balance_after: Includes 19,561 restricted stock units.

Read SEC document
January 05, 2021 Filed Jan 6, 2021 21:21 UTC
Roskey Mark T.SVP, Commercial & Accelerator
SaleCommon Stock 98 $44.13 $4,324.91
Disclosure

SEC source: 0001562180-21-000184 · primarydocument.xml · nonDerivative · entry 1

Roskey Mark T. · CIK 0001724565 · SVP, Commercial & Accelerator

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 21,837

F1 · shares: The sales of shares reported on this Form 4 were made solely to cover tax obligations upon the vesting of 298 RSUs.

F2 · price: This transaction was executed in multiple trades at prices ranging from $43.91 to $44.62. The price reported reflects the weighted average sale price. The reporting person undertakes to provide upon request to the SEC staff, the issuer or any security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

F3 · balance_after: Includes 14,667 restricted stock units.

Read SEC document
January 04, 2021 Filed Jan 5, 2021 18:22 UTC GrantStock Option (Right to Buy) · Derivative 7,900 $0.00 Strike: $44.11 $0.00
Disclosure

SEC source: 0001562180-21-000114 · primarydocument.xml · derivative · entry 3

Hlavinka Sarah E. · CIK 0001433554 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 7,900

Underlying: Common Stock · 7,900 shares

Expires 2031-01-04

F5 · shares: Represents non-qualified stock option to purchase 7,900 shares of common stock granted pursuant to the Quanterix Corporation 2018 Non-Employee Director Compensation Policy.

Read SEC document
January 04, 2021 Filed Jan 5, 2021 18:22 UTC GrantCommon Stock 269 $44.11 $11,865.59
Disclosure

SEC source: 0001562180-21-000114 · primarydocument.xml · nonDerivative · entry 2

Hlavinka Sarah E. · CIK 0001433554 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 11,268

F3 · shares: Consists of stock granted in lieu of cash fees for service on the Company's Board of Directors and committees thereof for the fourth quarter of 2020.

F4 · price: Closing price of the Company's common stock on the Nasdaq Global Market on January 4, 2021.

F2 · balance_after: Includes 5,297 restricted stock units.

Read SEC document
January 04, 2021 Filed Jan 5, 2021 18:22 UTC GrantCommon Stock 2,270 $0.00 $0.00
Disclosure

SEC source: 0001562180-21-000114 · primarydocument.xml · nonDerivative · entry 1

Hlavinka Sarah E. · CIK 0001433554 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 10,999

F1 · shares: Represents restricted stock units that vest as to 100% of the shares on December 31, 2021 granted pursuant to the Quanterix Corporation 2018 Non-Employee Director Compensation Policy. Each restricted stock unit represents the right to receive one share of the Issuer's common stock.

F2 · balance_after: Includes 5,297 restricted stock units.

Read SEC document
January 04, 2021 Filed Jan 5, 2021 22:54 UTC GrantStock Option (Right to Buy) · Derivative 7,900 $0.00 Strike: $44.10 $0.00
Disclosure

SEC source: 0001562180-21-000099 · primarydocument.xml · derivative · entry 4

Madaus Martin D · CIK 0001310268 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 7,900

Underlying: Common Stock · 7,900 shares

Expires 2031-01-04

F6 · shares: Represents non-qualified stock option to purchase 7,900 shares of common stock granted pursuant to the Quanterix Corporation 2018 Non-Employee Director Compensation Policy.

Read SEC document
January 04, 2021 Filed Jan 5, 2021 22:54 UTC GrantCommon Stock 410 $44.11 $18,085.10
Disclosure

SEC source: 0001562180-21-000099 · primarydocument.xml · nonDerivative · entry 2

Madaus Martin D · CIK 0001310268 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 14,396

F3 · shares: Consists of stock granted in lieu of cash fees for service on the Company's Board of Directors and committees thereof for the fourth quarter of 2020.

F4 · price: Closing price of the Company's common stock on the Nasdaq Global Market on January 4, 2021.

F2 · balance_after: Includes 2,270 restricted stock units.

Read SEC document
January 04, 2021 Filed Jan 5, 2021 22:54 UTC GrantCommon Stock 2,270 $0.00 $0.00
Disclosure

SEC source: 0001562180-21-000099 · primarydocument.xml · nonDerivative · entry 1

Madaus Martin D · CIK 0001310268 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 13,986

F1 · shares: Represents restricted stock units that vest as to 100% of the shares on December 31, 2021 granted pursuant to the Quanterix Corporation 2018 Non-Employee Director Compensation Policy. Each restricted stock unit represents the right to receive one share of the Issuer's common stock.

F2 · balance_after: Includes 2,270 restricted stock units.

Read SEC document
January 04, 2021 Filed Jan 5, 2021 22:45 UTC GrantStock Option (Right to Buy) · Derivative 7,900 $0.00 Strike: $44.10 $0.00
Disclosure

SEC source: 0001562180-21-000098 · primarydocument.xml · derivative · entry 3

MEISTER PAUL M · CIK 0001033876 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 7,900

Underlying: Common Stock · 7,900 shares

Expires 2031-01-04

F5 · shares: Represents non-qualified stock option to purchase 7,900 shares of common stock granted pursuant to the Quanterix Corporation 2018 Non-Employee Director Compensation Policy.

Read SEC document
January 04, 2021 Filed Jan 5, 2021 22:45 UTC GrantCommon Stock 311 $44.11 $13,718.21
Disclosure

SEC source: 0001562180-21-000098 · primarydocument.xml · nonDerivative · entry 2

MEISTER PAUL M · CIK 0001033876 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 13,207

F3 · shares: Consists of stock granted in lieu of cash fees for service on the Company's Board of Directors and committees thereof for the fourth quarter of 2020.

F4 · price: Closing price of the Company's common stock on the Nasdaq Global Market on January 4, 2021.

F2 · balance_after: Includes 2,270 restricted stock units.

Read SEC document
January 04, 2021 Filed Jan 5, 2021 22:45 UTC GrantCommon Stock 2,270 $0.00 $0.00
Disclosure

SEC source: 0001562180-21-000098 · primarydocument.xml · nonDerivative · entry 1

MEISTER PAUL M · CIK 0001033876 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 12,896

F1 · shares: Represents restricted stock units that vest as to 100% of the shares on December 31, 2021 granted pursuant to the Quanterix Corporation 2018 Non-Employee Director Compensation Policy. Each restricted stock unit represents the right to receive one share of the Issuer's common stock.

F2 · balance_after: Includes 2,270 restricted stock units.

Read SEC document
January 04, 2021 Filed Jan 5, 2021 18:12 UTC
WALT DAVID RDirector
GrantStock Option (Right to Buy) · Derivative 7,900 $0.00 Strike: $44.10 $0.00
Disclosure

SEC source: 0001562180-21-000113 · primarydocument.xml · derivative · entry 2

WALT DAVID R · CIK 0001205236 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 7,900

Underlying: Common Stock · 7,900 shares

Expires 2031-01-04

F3 · shares: Represents non-qualified stock option to purchase 7,900 shares of common stock granted pursuant to the Quanterix Corporation 2018 Non-Employee Director Compensation Policy.

Read SEC document
January 04, 2021 Filed Jan 5, 2021 18:12 UTC
WALT DAVID RDirector
GrantCommon Stock 2,270 $0.00 $0.00
Disclosure

SEC source: 0001562180-21-000113 · primarydocument.xml · nonDerivative · entry 1

WALT DAVID R · CIK 0001205236 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,278,644

F1 · shares: Represents restricted stock units that vest as to 100% of the shares on December 31, 2021 granted pursuant to the Quanterix Corporation 2018 Non-Employee Director Compensation Policy. Each restricted stock unit represents the right to receive one share of the Issuer's common stock.

F2 · balance_after: Includes 2,270 restricted stock units.

Read SEC document
January 04, 2021 Filed Jan 5, 2021 18:08 UTC GrantStock Option (Right to Buy) · Derivative 7,900 $0.00 Strike: $44.10 $0.00
Disclosure

SEC source: 0001562180-21-000112 · primarydocument.xml · derivative · entry 2

DEKKERS MARIJN E · CIK 0001216068 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 7,900

Underlying: Common Stock · 7,900 shares

Expires 2031-01-04

F3 · shares: Represents non-qualified stock option to purchase 7,900 shares of common stock granted pursuant to the Quanterix Corporation 2018 Non-Employee Director Compensation Policy.

Read SEC document
January 04, 2021 Filed Jan 5, 2021 18:08 UTC GrantCommon Stock 2,270 $0.00 $0.00
Disclosure

SEC source: 0001562180-21-000112 · primarydocument.xml · nonDerivative · entry 1

DEKKERS MARIJN E · CIK 0001216068 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 9,080

F1 · shares: Represents restricted stock units that vest as to 100% of the shares on December 31, 2021 granted pursuant to the Quanterix Corporation 2018 Non-Employee Director Compensation Policy. Each restricted stock unit represents the right to receive one share of the Issuer's common stock.

F2 · balance_after: Includes 2,270 restricted stock units.

Read SEC document
January 04, 2021 Filed Jan 5, 2021 23:04 UTC
CRANDELL KEITHDirector · 10% owner
GrantStock Option (Right to Buy) · Derivative 7,900 $0.00 Strike: $44.10 $0.00
Disclosure

SEC source: 0001562180-21-000111 · primarydocument.xml · derivative · entry 5

CRANDELL KEITH · CIK 0001219039 · Director · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 7,900

Underlying: Common Stock · 7,900 shares

Expires 2031-01-04

F7 · shares: Represents non-qualified stock option to purchase 7,900 shares of common stock granted pursuant to the Quanterix Corporation 2018 Non-Employee Director Compensation Policy.

Read SEC document
January 04, 2021 Filed Jan 5, 2021 23:04 UTC
CRANDELL KEITHDirector · 10% owner
GrantCommon Stock 197 $44.11 $8,689.67
Disclosure

SEC source: 0001562180-21-000111 · primarydocument.xml · nonDerivative · entry 2

CRANDELL KEITH · CIK 0001219039 · Director · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 14,426

F3 · shares: Consists of stock granted in lieu of cash fees for service on the Company's Board of Directors and committees thereof for the fourth quarter of 2020.

F4 · price: Closing price of the Company's common stock on the Nasdaq Global Market on January 4, 2021.

F2 · balance_after: Includes 2,270 restricted stock units.

Read SEC document
January 04, 2021 Filed Jan 5, 2021 23:04 UTC
CRANDELL KEITHDirector · 10% owner
GrantCommon Stock 2,270 $0.00 $0.00
Disclosure

SEC source: 0001562180-21-000111 · primarydocument.xml · nonDerivative · entry 1

CRANDELL KEITH · CIK 0001219039 · Director · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 14,229

F1 · shares: Represents restricted stock units that vest as to 100% of the shares on December 31, 2021 granted pursuant to the Quanterix Corporation 2018 Non-Employee Director Compensation Policy. Each restricted stock unit represents the right to receive one share of the Issuer's common stock.

F2 · balance_after: Includes 2,270 restricted stock units.

Read SEC document
December 18, 2020 Filed Dec 21, 2020 22:03 UTC
Duffy David C.SVP R&D and CTO
Exercise / conversionStock Option (Right to buy) · Derivative 1,630 $0.00 Strike: $2.28 $0.00
Disclosure

SEC source: 0001562180-20-007392 · primarydocument.xml · derivative · entry 3

Duffy David C. · CIK 0001724566 · SVP R&D and CTO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 21,023

Underlying: Common Stock · 1,630 shares

Expires 2022-02-03

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · derivative.exercise_date: Option is fully vested.

Read SEC document
December 18, 2020 Filed Dec 21, 2020 22:03 UTC
Duffy David C.SVP R&D and CTO
SaleCommon Stock 1,667 $43.82 $73,047.94
Disclosure

SEC source: 0001562180-20-007392 · primarydocument.xml · nonDerivative · entry 2

Duffy David C. · CIK 0001724566 · SVP R&D and CTO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 41,140

F1 · shares: The sale of shares reported on this Form 4 was made pursuant to a Rule 10b5-1 trading plan adopted on May 15, 2020.

F2 · balance_after: Includes 11,620 restricted stock units.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.